Phosphatidylserine COA vs Third-Party Lab Discrepancies: A Resolution Protocol for US and EU Buyers

A quarantined lot of phosphatidylserine with a disputed assay is one of the most expensive situations in ingredient procurement: production is waiting, the supplier is defending its COA, your third-party laboratory is confident in its number, and every week of delay costs more than the testing did. Most of these disputes drag on because nobody first established what the two results are actually measuring.

Discrepancies have a small set of causes — different methods, different sample basis, sample identity, or a genuinely non-conforming lot. A protocol that walks those causes in order turns a weeks-long argument into a two-week investigation with a documented outcome.

Why PS Disagrees: The Method Landscape Behind the COA

Phosphatidylserine content is not measured one way across the industry. Supplier COAs commonly report assay by enzymatic or colorimetric phosphorus-based methods, chromatographic methods with evaporative or ultraviolet detection, or a calculation from total phosphorus and phosphatidylcholine/inositol corrections. These approaches do not produce identical numbers on the same powder; differences of several percentage points between method families are normal, and each carries its own bias against different phospholipid mixtures.

Two structural factors make PS more dispute-prone than most actives:

• Reference standards for phosphatidylserine are expensive and less universally available than for mainstream actives, so calibration quality varies between laboratories.
• "Phosphatidylserine content" can be reported as pure PS, as a phospholipid complex, or on a dry versus as-is basis — a 5% moisture difference moves a 50% assay by 2.5 absolute points with no chemistry change at all.

This is why the first question in any dispute is not "whose lab is right" but "are these two numbers the same measurement".

Step One: Confirm You Are Comparing the Same Numbers

Before any retesting, build a comparison table with four rows: method (named, not "HPLC"), reporting basis (as-is or dry), unit definition (pure PS versus complex), and specification limit with its basis. Pull the supplier's full method — or at least its method summary — and your third-party lab's method, and put them side by side.

Common wins in this step:

• Supplier reported dry basis, your lab reported as-is (or the reverse) — the discrepancy shrinks or disappears after moisture correction against the COA's own water result.
• Supplier reported the phospholipid complex, your lab quantified pure PS — a definitional mismatch, not a failure.
• Both reports say "HPLC" but with different detection and different calibration standards — a real method difference that needs a head-to-head test, not a desk comparison.

Document the outcome either way. If the discrepancy is fully explained, close with a written reconciliation and correct the purchase specification to state the basis explicitly — that specification gap is the root cause.

Step Two: Sampling and Sample Identity

If the numbers were comparable and still disagree, verify the samples. Powdered phospholipids can be heterogeneous after long ocean transit — oils and fines migrate, and a scoop from the drum top is not a drum average. Check:

• Which container and which sampling location each lab received; increment sampling across the drum with a documented plan beats a single grab.
• Sample integrity: transit temperature for a summer container, resealing, hold times. An oxidised or moisture-shifted sample can legitimately test different from the retained reference.
• Chain of custody: lot numbers, sub-sample labels and transfer records. A mislabelled sub-sample produces a confident, wrong answer.

If sampling practice is suspect, the resolution is a fresh, joint, documented sample — drawn per an agreed plan, split into three sealed sets (supplier, buyer, referee), with custody signed at each handoff.

Step Three: The Retention Sample Retest

The supplier's retention sample from the same lot is the anchor experiment: it was drawn at release, stored under controlled conditions, and represents what the supplier certified. Send it — blind-labelled if the supplier agrees — to an ISO/IEC 17025-accredited third-party laboratory using a method both parties accept in advance.

The retest matrix that resolves most disputes in one round:

• Retention sample, agreed referee method — tests the supplier's release result and calibration.
• Your original disputed sample, same referee method — tests whether the lot differs from its retention.
• Moisture on both — puts everything on one basis.

Three outcome patterns follow. Retention passes and your sample fails: the lot changed in transit or your sample is unrepresentative — investigate logistics and sampling before condemning chemistry. Both fail by the referee method: the lot is non-conforming; move to disposition. Both pass: your original lab's method or calibration was off — close the dispute and requalify that method.

Root Cause Branches: Method Artefact, Sampling Error, or Real Failure

Write the conclusion into one of three branches, because each drives a different action:

• Method artefact: results reconcile once basis, method and calibration are aligned. Action: amend the purchase specification to name the method, basis and unit; agree the referee laboratory for future verification; no lot action.
• Sampling or logistics error: retention conforms, delivered lot does not (or sampling was undocumented). Action: joint sampling protocol for future lots; review transit packaging and season; test remaining drums individually to bound the affected population before any use decision.
• Genuine non-conformance: referee method confirms the delivered lot fails specification. Action: reject or concession per the quality agreement; supplier investigates root cause under CAPA; check retention stability history and neighbouring lots shipped to you.

Disposition, Cost Allocation and the Paper Trail

Disposition decisions belong to the buyer's quality system: reject, accept with documented justification, or rework at supplier cost where physically possible. What should not happen is "accept and move on" without a written rationale — under US dietary supplement GMP your release decision relies on your own verification, and EU food law expects the operator's verification to be documented.

Cost allocation should follow the quality agreement's dispute clause; where none exists, the defensible default is: each party bears its own original testing; the referee retest is paid by whichever party's position the referee result rejects, or split when the root cause is a shared specification ambiguity. File the reconciliation — comparison table, referee reports, custody records, root cause, disposition — in the supplier's qualification file; it becomes evidence of a controlled verification process at your next audit.

Writing the Specification So the Next Dispute Is Cheap

Every dispute closes with a specification amendment. The four clauses that prevent recurrence:

1. Named assay method (or a declared acceptable-method list) with the reporting basis — as-is or dry — stated on the same line as the limit.
2. Defined unit: pure phosphatidylserine versus complex, with what is excluded from the quantitation.
3. A named referee laboratory and referee method for disputes, agreed in advance.
4. A dispute clause: joint sampling, retention sample access, retest scope, timing, and cost allocation.

FAQ

Q: Why do phosphatidylserine assay results differ between laboratories?

A: Different method families — enzymatic or phosphorus-based versus chromatographic with different detection and calibration standards — plus reporting-basis differences (as-is versus dry) and unit definitions (pure PS versus complex). Differences of several percentage points between method families are normal.

Q: What is the first step when a third-party result contradicts the supplier COA?

A: Build a comparison table: named methods, moisture basis, unit definition and specification basis. Many disputes close at this step because the two numbers were never measuring the same thing.

Q: Why retest the supplier's retention sample?

A: It was drawn at release under controlled storage, so it separates "the lot failed" from "the lot changed or the sample was unrepresentative". A retention pass with a delivered-lot failure points to transit or sampling; both failing under a referee method confirms non-conformance.

Q: Who pays for retesting a disputed lot?

A: Per the quality agreement's dispute clause if one exists. Otherwise a defensible default: each party bears its own original costs, and the referee retest is charged to the party whose position the referee result rejects, or split if the root cause was a shared specification ambiguity.

Q: When is a discrepancy a rejection?

A: When the delivered lot fails the agreed referee method on a properly documented, representative sample — after method and basis alignment. Then disposition follows your quality system and the supplier runs root cause and CAPA.

Conclusion

A COA-versus-lab discrepancy on phosphatidylserine is an investigation, not an argument. Align the numbers first — method, basis, unit — then test sample identity, then run the retention-versus-delivered retest under an agreed referee method. One structured round resolves most disputes and tells you whether the answer is a specification amendment, a sampling fix, or a rejected lot.

The buyers who resolve these fastest are the ones who wrote the method, the basis and the referee clause into the specification before the first dispute — the cheapest time to do it is today.

Sources

• U.S. Food and Drug Administration (FDA) — Current Good Manufacturing Practice for Dietary Supplements, testing and specification requirements (21 CFR Part 111): https://www.fda.gov/food/current-good-manufacturing-practice-cgmp-dietary-supplements
• ISO/IEC 17025:2017 — General requirements for the competence of testing and calibration laboratories: https://www.iso.org/standard/66912.html
• AOAC International — Official Methods of Analysis and laboratory proficiency testing programs: https://www.aoac.org/
• European Commission — Regulation (EC) No 178/2002, General Food Law (operators' verification and traceability obligations): https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX%3A32002R0178
• United States Pharmacopeia (USP) — Dietary supplements chapters and reference standards: https://www.usp.org/dietary-supplements

Recommended next steps

• Review the Phosphatidylserine product page.
• Compare Soy PS and Sunflower PS.
• Check manufacturing proof and Quality & R&D.